Yeh T, Yeung M, Sherman EJ, Tuttle RM MD, et al. Structural doubling time predicts overall survival in patients with medullary thyroid cancer in patients with rapidly progressive metastatic medullary thyroid cancer treated with molecular targeted therapies. Thyroid 2020 Mar 4. doi: 10.1089/thy.2019.0579.
PMID: 32131709